In Global News: Ex Vivo Lung Perfusion, the Future of TMVR, and an App That Beats the Allen Test [1]
Patient Care
Michael Mack and Alec Vahanian discuss the state and future of transcatheter mitral valve replacement [3].
A new guideline on the use of endoscopic eradication therapy in Barrett’s esophagus [4] published by the American Society for Gastrointestinal Endoscopy recommends against surgery [5] for patients with high-grade dysplasia and intramucosal esophageal adenocarcinoma.
Drugs and Devices
Researchers found that a smartphone app evaluates blood flow in radial and ulnar arteries prior to coronary angiography [6] with higher accuracy than the traditional Allen test.
Research, Trials, and Funding
A man in Texas, USA, became one of the first recipients of lungs transplanted using ex vivo lung perfusion [7], as part of the EXPAND II OCS trial.
Chronic thromboembolic hypertension was one of the topics [8] at the ongoing Annual Meeting of the International Society for Heart and Lung Transplantation in Nice, France. Another session focused on DCD heart transplantation and ex vivo heart perfusion [9].
Researchers in Michigan, USA, found that patients undergoing coronary revascularization after the 2014 Medicaid insurance expansion [10] in the USA had outcomes comparable to those for patients who underwent revascularization before the expansion.